18.44
전일 마감가:
$18.16
열려 있는:
$18.54
하루 거래량:
17,891
Relative Volume:
0.83
시가총액:
$1.28B
수익:
$277.56M
순이익/손실:
$-13.33M
주가수익비율:
-97.05
EPS:
-0.19
순현금흐름:
$-6.54M
1주 성능:
-1.44%
1개월 성능:
+11.15%
6개월 성능:
+79.92%
1년 성능:
+93.60%
Pharming Group N V Adr Stock (PHAR) Company Profile
PHAR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
PHAR
Pharming Group N V Adr
|
18.44 | 1.27B | 277.56M | -13.33M | -6.54M | -0.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Pharming Group N V Adr Stock (PHAR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-09 | 개시 | Jefferies | Buy |
Pharming Group N V Adr 주식(PHAR)의 최신 뉴스
Pharming Group (NASDAQ:PHAR) Shares Gap Down After Analyst Downgrade - Defense World
Pharming Group (NASDAQ:PHAR) Cut to Hold at Zacks Research - Defense World
Pharming Group (NASDAQ:PHAR) Shares Gap DownHere's What Happened - MarketBeat
Pharming Group (NASDAQ:PHAR) Trading Up 4.4% – Here’s Why - Defense World
Pharming Group (NASDAQ:PHAR) Hits New 1-Year High – Still a Buy? - Defense World
Short Interest in Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Rises By 102.0% - MarketBeat
Best Momentum Stocks to Buy for Dec. 22 - Yahoo Finance Singapore
Pharming Group (NASDAQ:PHAR) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Pharming Group (NASDAQ:PHAR) Hits New 12-Month HighShould You Buy? - MarketBeat
Pharming Group (NASDAQ:PHAR) Sees Large Volume IncreaseShould You Buy? - MarketBeat
Operating expenses (excl. COGS) of Pharming Group NV Sponsored ADR – LSX:A2QLQY - TradingView
Pharming Group (NASDAQ:PHAR) Stock Price Up 11%Time to Buy? - MarketBeat
Pharming Group (NASDAQ:PHAR) Sets New 12-Month HighStill a Buy? - MarketBeat
Wall Street Analysts Believe Pharming Group (PHAR) Could Rally 81.71%: Here's is How to Trade - MSN
Pharming Group (NASDAQ:PHAR) Sees Strong Trading VolumeWhat's Next? - MarketBeat
Pharming Group (NASDAQ:PHAR) Shares Up 8.6%Time to Buy? - MarketBeat
Earnings Estimates Moving Higher for Pharming Group (PHAR): Time to Buy? - MSN
Does Pharming Group (PHAR) Have the Potential to Rally 100.91% as Wall Street Analysts Expect? - sharewise.com
FY2025 EPS Estimates for Pharming Group Raised by Analyst - Defense World
Pharming Group (NASDAQ:PHAR) Sees Large Volume Increase After Better-Than-Expected Earnings - Defense World
Pharming Group (NASDAQ:PHAR) Shares Gap Up After Better-Than-Expected Earnings - Defense World
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Update - MarketBeat
Pharming Group (PHAR) to Release Earnings on Thursday - Defense World
Pharming Group (NASDAQ:PHAR) Upgraded at Weiss Ratings - Defense World
Pharming Group (NASDAQ:PHAR) Shares Up 9.5%What's Next? - MarketBeat
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Down 71.8% in September - MarketBeat
Short Interest in Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Increases By 64.2% - MarketBeat
Pharming Group (NASDAQ:PHAR) Stock Price Down 4.6%What's Next? - MarketBeat
Pharming Group (NASDAQ:PHAR) Stock Price Up 7%Still a Buy? - MarketBeat
Pharming Group (NASDAQ:PHAR) Shares Gap UpTime to Buy? - MarketBeat
QURE Stock Skyrockets on Meeting Goals in Huntington's Disease Study - Finviz
Pharming Group (NASDAQ:PHAR) Shares Gap Up – Still a Buy? - Defense World
Pharming Group (NASDAQ:PHAR) Stock Price Down 4.4%What's Next? - MarketBeat
Short Interest in Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Increases By 378.6% - MarketBeat
Pharming Group N V Adr (PHAR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):